NRCME Psychological Condition Protocols 4

Question 1

A CMV driver applicant discloses a history of bipolar I disorder and reports being stable on lithium for 4 years with no hospitalizations. During the examination, he presents documentation from his psychiatrist confirming euthymic mood and full occupational functioning. Which action best reflects the NRCME protocol for this scenario?

Accepted Answer

Certify for 1 year with a requirement for annual psychiatric clearance letters confirming continued stability and medication compliance

Answer

Bipolar I disorder is not a per se disqualifying condition, but it requires individualized assessment. FMCSA guidance instructs medical examiners to certify drivers with treated psychiatric conditions at reduced intervals (typically 1 year) when documentation supports stability, medication compliance, and absence of acute episodes. A 2-year certificate is inappropriate given the ongoing psychiatric risk factor, and permanent disqualification is not warranted without current disqualifying behavior or functional impairment.

Question 2

A driver applying for CMV certification has a diagnosis of PTSD following a combat-related trauma. He is currently prescribed prazosin for nightmares and sertraline for anxiety. His treating provider states he is 'doing well.' Under NRCME psychological condition protocols, which factor is MOST critical in determining whether this driver can be certified?

Accepted Answer

Whether the medications cause sedation, impaired vigilance, or other side effects that could affect driving safety

Answer

FMCSA regulations require evaluation of whether medications used to treat psychological conditions cause side effects that impair driving ability. Both sertraline (an SSRI) and prazosin must be reviewed for effects such as sedation, dizziness, hypotension, or blunted alertness. The duration since the trauma, hospitalization history, and military branch are secondary considerations. Functional impairment from treatment is the most operationally relevant safety variable.

Question 3

During a DOT physical, a driver denies any history of mental health treatment. However, the medical examiner notices multiple inconsistencies in the driver's responses and observes psychomotor agitation, pressured speech, and grandiose statements about a new business venture. The driver does not volunteer any psychiatric history. What is the MOST appropriate examiner action?

Accepted Answer

Document observations, probe further with targeted questions about sleep, mood changes, and past episodes, and defer certification pending psychiatric evaluation if concerns persist

Answer

NRCME protocol requires the examiner to use clinical judgment beyond self-report. Observable signs suggesting acute mania (pressured speech, grandiosity, psychomotor agitation) are clinically significant and create a duty to probe further. Deferring certification pending psychiatric evaluation is appropriate when the examiner has reasonable clinical concern. Immediate permanent disqualification without further workup would be premature; relying solely on self-report ignores the examiner's clinical observation responsibility.

Question 4

A driver presents with a well-documented history of major depressive disorder, currently managed with bupropion XL 450 mg/day. His psychiatrist certifies he has been in full remission for 18 months. The medical examiner notes the bupropion dose is at the upper therapeutic limit. Which is the MOST accurate statement regarding certification under NRCME protocol?

Accepted Answer

Bupropion is not federally disqualifying, but the examiner should evaluate for dose-related side effects including seizure risk, insomnia, and tachycardia that may affect safe driving

Answer

Bupropion is not listed as a per se disqualifying medication under FMCSA rules. However, at doses of 450 mg/day (the upper approved limit), the seizure risk increases compared to lower doses, and side effects such as insomnia, tachycardia, and anxiety are more common. The examiner must evaluate these dose-related risks as part of individualized assessment. A 2-year certificate may be inappropriate given ongoing pharmacotherapy, and a specialist letter supplements but does not replace the examiner's independent clinical judgment.

Question 5

A driver previously disqualified due to a schizophrenia diagnosis presents for recertification after 3 years. He provides documentation showing he has been on a long-acting injectable antipsychotic (paliperidone palmitate monthly) for 2 years, has had no psychotic episodes, and holds a part-time job. His psychiatrist supports return to CMV driving. Under FMCSA/NRCME guidance, which statement is MOST accurate?

Accepted Answer

Schizophrenia is not a permanent per se disqualifier; the examiner must conduct individualized evaluation of current functional status, symptom control, medication side effects, and insight, and may certify if safety standards are met

Answer

FMCSA regulations do not categorically and permanently disqualify drivers with schizophrenia. The standard is whether the driver currently meets the physical and mental qualifications to operate a CMV safely. Individualized evaluation — including symptom remission, insight into illness, medication adherence, side effects (e.g., tardive dyskinesia, sedation, orthostatic hypotension from paliperidone), and functional capacity — governs the decision. LAI antipsychotics actually improve adherence reliability and are not inherently disqualifying. A 1-year certification interval is typically more appropriate than a full 2-year certificate for ongoing psychiatric conditions.

NRCME - National Registry of Certified Medical Examiners Practice Test

NRCME - National Registry of Certified Medical Examiners Practice Test

NRCME Psychological Condition Protocols 4